HomeFinTechRace Oncology: Reports $1.8m in cash outflows

Race Oncology: Reports $1.8m in cash outflows

Related stories

Lunar Achieves Milestone as First Scandinavian Provider to Obtain MiCA Crypto License

Revolutionizing the Crypto Landscape in Scandinavia: Lunar's Groundbreaking License...

Monzo Integrates Built-in Tax Filing Tool for Enhanced Customer Experience

Simplifying Tax Season: How Monzo's New Feature Aims to...

Former Klarna UK Chief Alex Marsh Named CEO of Salad Group

Fintech veteran Alex Marsh takes the helm at Salad...

Visa Launches Trusted Agent Protocol for AI Commerce

Innovative Security Framework Enhances Trust in AI-Driven Transactions Highlights: Visa...

FCA’s Strategic Initiatives for Tokenisation of Investment Funds

A Comprehensive Overview of the UK Financial Conduct Authority's...

Race Oncology Reports $1.8m in cash outflows

  • Race Oncology (RAC) reports $1.8 million in cash outflows for the quarter, an increase from the $931,000 in outflows recorded in the previous quarter
  • The company spent $890,000 during the period for research and development
  • RAC’s focus is Zantrene, a small molecule anti-cancer drug in which the company announced numerous achievements for over the quarter
  • At the end of the period, the company had $37.1 million in cash and cash equivalents
  • Shares closed 2.81 per cent higher today at $2.93 each
Exit mobile version